CVG:FRA
CSPC Pharmaceutical Group Ltd
€1.04
arrow_downward
-0.76%(-0.0080) 1D
Sep 7, 2:02:52 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CVG...
Open
€1.04
High
€1.04
Low
€1.04
Mkt. cap
111.48B
Avg. vol.
1.01K
Volume
165.00
52-wk high
€1.25
52-wk low
€0.73
No. of employees
19K
Open
€1.04
High
€1.04
Low
€1.04
Mkt. cap
111.48B
Avg. vol.
1.01K
Volume
165.00
52-wk high
€1.25
52-wk low
€0.73
No. of employees
19K
News stories
From web sources and news partners
TipRanks
·
4 hours ago
CSPC Launches Phase II Trial of Novel Influenza Drug in China
Profile
CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province.
CSPC produces both active pharmaceutical ingredient and formulations. API products include
penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products.
CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP.
CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises.
One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion.
CSPC Pharma is recognized as one of China's "500 Most Valuable Chinese Brands" and "Top 500 Chinese Enterprises." Wikipedia
About CSPC Pharmaceutical Group Ltd
CEOZhang Cuilong
Employees18.6K
Founded1992
Headquarters-
SectorPharmaceutical industry
Websitecspc.com.hk